These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11145797)

  • 1. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis.
    Drake L; Prendergast M; Maher R; Breneman D; Korman N; Satoi Y; Beusterien KM; Lawrence I
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S65-72. PubMed ID: 11145797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.
    Won CH; Seo PG; Park YM; Yang JM; Lee KH; Sung KJ; Park CW; Kim DW; Chang HS; Won YH; Kim KH
    J Dermatolog Treat; 2004 Jan; 15(1):30-4. PubMed ID: 14754647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids.
    Poole CD; Chambers C; Allsopp R; Currie CJ
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):674-8. PubMed ID: 20565562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
    Kawashima M;
    Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.
    Paller A; Eichenfield LF; Leung DY; Stewart D; Appell M
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S47-57. PubMed ID: 11145795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.
    Boguniewicz M; Fiedler VC; Raimer S; Lawrence ID; Leung DY; Hanifin JM
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):637-44. PubMed ID: 9802373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy.
    Hanifin JM; Ling MR; Langley R; Breneman D; Rafal E
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S28-38. PubMed ID: 11145793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study.
    Poole CD; Chambers C; Sidhu MK; Currie CJ
    Br J Dermatol; 2009 Dec; 161(6):1335-40. PubMed ID: 19754867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy of tacrolimus ointment and impact on quality of life.
    Kondo Y; Nakajima Y; Komatsubara R; Kato M; Hirata N; Matuyama H; Kakami M; Tsuge I; Ohya Y; Urisu A
    Pediatr Int; 2009 Jun; 51(3):385-9. PubMed ID: 19400811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole.
    Ständer S; Yosipovitch G; Bushmakin AG; Cappelleri JC; Luger T; Tom WL; Ports WC; Zielinski MA; Tallman AM; Tan H; Gerber RA
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1742-1746. PubMed ID: 31132182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe treatment of head/neck AD with tacrolimus ointment.
    Kang S; Paller A; Soter N; Satoi Y; Rico MJ; Hanifin JM
    J Dermatolog Treat; 2003 Jun; 14(2):86-94. PubMed ID: 12775315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections.
    Fleischer AB; Ling M; Eichenfield L; Satoi Y; Jaracz E; Rico MJ; Maher RM;
    J Am Acad Dermatol; 2002 Oct; 47(4):562-70. PubMed ID: 12271302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Kang S; Lucky AW; Pariser D; Lawrence I; Hanifin JM
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S58-64. PubMed ID: 11145796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
    Ingram JR; Martin JA; Finlay AY
    Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.